Vimarsana
Biggest News Aggregation in the World

Page 5 - Assure Tech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Assure Tech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Assure Tech Today - Breaking & Trending Today

Chinese test kit producers scramble to meet surging overseas orders - Vimarsana News

Chinese test kit producers scramble to meet surging overseas orders

Chinese test kit makers have ramped up workers recruiting and plant production amid booming overseas orders, especially from the US where the Omicron variant is spreading across the states.

Australia COVID: The entrepreneurs riding the rapid test rollercoaster - Vimarsana News

Australia COVID: The entrepreneurs riding the rapid test rollercoaster

Some well-known names are meeting Australia’s insatiable demand for rapid coronavirus tests.

Source: afr.com
Therapeutic Goods Administration approves 18 rapid antigen tests but most are sold out - Vimarsana News

Therapeutic Goods Administration approves 18 rapid antigen tests but most are sold out

The most effective rapid antigen tests are made in China. It is also supplying two-thirds of the 18 home testing kits that have been approved for use in Australia. New rules come into force on January 8.

Home Diagnostics Market will progress at a CAGR of around 5% over the period of 2022 to 2030 - Vimarsana News

Home Diagnostics Market will progress at a CAGR of around 5% over the period of 2022 to 2030

The coronavirus pandemic has led to rapid rise in the demand for home diagnostic equipment. Individuals with health issues such as diabetes and other chronic diseases are likely to be affected by Covid-19 worse than others, and, as such, need to keep their health in check to avoid any complications.Practice of diagn...

Very high rates of asymptomatic infection with Omicron compared to prior SARS-CoV-2 variants - Vimarsana News

Very high rates of asymptomatic infection with Omicron compared to prior SARS-CoV-2 variants

The advent of the B.1.1.529 (Omicron) severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) variant, detected initially in Botswana and South Africa and now found in over 135 countries as of January 3, 2022, has sparked fears of a new global wave of infections and hospitalizations